German Botulinum Toxin Therapy Accessibility and Utilization Survey, 2023-2024

191 survey responses from the German Botulinum Toxin Working Group collected between November 2023 and March 2024. The dataset includes a geospatial analysis of travel times to neurological BoNT-A centers in Germany and survey results documenting physician experiences and perceived barriers to therapy. The data was authored by Tristan Koelsche and published on figshare under a CC-BY-4.0 license.

Use Cases

• Model geographic accessibility to specialized care based on the 60-minute drive time analysis.
• Identify structural barriers to treatment adoption based on survey responses about reimbursement and collaboration.
• Analyze physician perception of therapy effectiveness based on the survey's indication ratings.
• Study the discrepancy between theoretical access and real-world utilization in a well-resourced healthcare system.

Strengths

• Includes a geospatial analysis covering 96.72% of the German population.
• Survey respondents include 79.6% neurologists and two-thirds with over 10 years of BoNT-A experience.
• Data is recent, collected between November 2023 and March 2024.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is contained in a 243.1 KB PDF file, which may require extraction for analysis.

Provenance

Source

German Botulinum Toxin Working Group (Arbeitskreis Botulinumtoxin e. V.; AK-BoNT) and German hospital quality reports.

Collection Method

Anonymous online survey of AK-BoNT members and geospatial analysis of travel times.

Time Range

Survey conducted November 2023 to March 2024.

Freshness

Last updated 2026-03-17 13:06:36; freshness should be verified.

Geography

Germany